Utah Medical Products, Inc.
UTMD
Market Cap$192.68M
Close$
$111.68
95.8% upside
Current Fair Value
95.8% upsideUndervalued by 95.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $192.68 Million |
|---|---|
| Enterprise Value | $110.12 Million |
| Dividend Yield | $1.21 (2.12990670656575%) |
| Earnings per Share | $3.96 |
| Beta | 0.06 |
| Outstanding Shares | 3,388,002 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.87 |
|---|---|
| PEG | -147.14 |
| Price to Sales | 4.39 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 2.5 |
| Enterprise Value to EBIT | 7.13 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...